Cargando…
The progression of doxorubicin-induced intestinal mucositis in rats
Chemotherapy-induced intestinal mucositis is a severe side effect contributing to reduced quality of life and premature death in cancer patients. Despite a high incidence, a thorough mechanistic understanding of its pathophysiology and effective supportive therapies are lacking. The main objective o...
Autores principales: | Kullenberg, F., Peters, K., Luna-Marco, C., Salomonsson, A., Kopsida, M., Degerstedt, O., Sjöblom, M., Hellström, P. M., Heindryckx, F., Dahlgren, D., Lennernäs, H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9832110/ https://www.ncbi.nlm.nih.gov/pubmed/36271936 http://dx.doi.org/10.1007/s00210-022-02311-6 |
Ejemplares similares
-
Chemotherapeutics-Induced Intestinal Mucositis: Pathophysiology and Potential Treatment Strategies
por: Dahlgren, David, et al.
Publicado: (2021) -
Evaluation and validation of chemotherapy‐specific diarrhoea and histopathology in rats
por: Dahlgren, David, et al.
Publicado: (2022) -
In Vitro Cell Toxicity and Intracellular Uptake of Doxorubicin Exposed as a Solution or Liposomes: Implications for Treatment of Hepatocellular Carcinoma
por: Kullenberg, Fredrik, et al.
Publicado: (2021) -
Chemotherapeutics Combined with Luminal Irritants: Effects on Small-Intestinal Mannitol Permeability and Villus Length in Rats
por: Cano-Cebrián, Maria-José, et al.
Publicado: (2022) -
Melatonin-Activated Receptor Signaling Pathways Mediate Protective Effects on Surfactant-Induced Increase in Jejunal Mucosal Permeability in Rats
por: Peters, Karsten, et al.
Publicado: (2021)